Drugs / Promestriene

Trials 2

20112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 31 trial · 1 missed
Phase 3 NCT01370798 May 2011 → Sep 2017 hypospadias Hospices Civils de Lyon Completed Missed primary
Phase 41 trial
Phase 4 NCT05863975 Jul 2023 → Dec 2025 human papilloma virus infection Qianfoshan Hospital Unknown No outcome recorded
Comparator or background therapy6 trials
Phase 3 NCT04232813 Comparator Jan → Jun 2020 postmenopausal atrophic vaginitis Instituto Palacios Completed No outcome recorded
Phase 4 NCT07153276 Comparator Feb 2026 → Sep 2029 expected Sjogren syndrome University of Sao Paulo General Hospital Recruiting No outcome recorded
Phase 4 NCT03032848 Comparator Nov 2013 → Dec 2016 endometrial disorder, pelvic organ prolapse, postmenopausal atrophic vaginitis Federal University of Paraná Completed No outcome recorded
— NCT04657536 Comparator Dec 2020 → Dec 2021 postmenopausal atrophic vaginitis Peking University People's Hospital Unknown No outcome recorded
— NCT04081805 Comparator Sep 2019 → Sep 2025 overdue breast cancer, postmenopausal atrophic vaginitis Federal University of São Paulo Active not recruiting No outcome recorded

Evidence & citations 5 cited values

Every value below carries the sentence it was read from. 10 sources stand behind the page.

FieldValueCited text
Known as promestriene “② Promestriene group: promestriene cream vaginal medication.” NCT05863975 ↗
7

NCT04081805 ↗

NCT04232813 ↗

NCT01370798 ↗

NCT04657536 ↗

NCT03032848 ↗

NCT07153276 ↗

NCT04717245 ↗

Known as Colpotrophine ChEMBL registry synonym — accepted as the source's own label CHEMBL2105394 ↗
Known as Promestrieno ChEMBL registry synonym — accepted as the source's own label CHEMBL2105394 ↗
Modality Other / unclassified “promestriene topical estrogen” PMID 38714422 ↗ Apr 2024
Route Topical “Promestriene cream 1%, 1g per day during 2 months, cutaneous application” NCT01370798 ↗